Monsanto Company (NYSE:MON)‘s stock had its “buy” rating reiterated by equities research analysts at BMO Capital Markets in a note issued to investors on Thursday. They currently have a $128.00 target price on the basic materials company’s stock. BMO Capital Markets’ target price would indicate a potential upside of 6.91% from the company’s previous close.

MON has been the subject of a number of other reports. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a report on Thursday, September 14th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Macquarie downgraded Monsanto from an “outperform” rating to a “neutral” rating in a report on Wednesday. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a report on Tuesday, June 27th. Finally, Barclays PLC lifted their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $125.45.

Shares of Monsanto (NYSE:MON) opened at 119.73 on Thursday. The company has a market capitalization of $52.62 billion, a PE ratio of 23.53 and a beta of 1.07. The firm’s 50-day moving average price is $118.25 and its 200 day moving average price is $117.04. Monsanto has a one year low of $97.35 and a one year high of $120.50. Monsanto also saw unusually large options trading on Wednesday. Stock investors purchased 63,484 put options on the company. This represents an increase of 1,793% compared to the average daily volume of 3,354 put options.

Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.41) by $0.61. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. During the same period last year, the company earned $0.07 earnings per share. The firm’s revenue was up 4.8% compared to the same quarter last year. Analysts anticipate that Monsanto will post $5.65 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/10/07/monsanto-company-mon-stock-rating-reaffirmed-by-bmo-capital-markets.html.

In other Monsanto news, VP Duraiswami Narain sold 2,860 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The stock was sold at an average price of $120.00, for a total value of $343,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $120.03, for a total value of $2,717,479.20. Following the completion of the sale, the chief operating officer now directly owns 85,439 shares of the company’s stock, valued at approximately $10,255,243.17. The disclosure for this sale can be found here. Insiders sold 77,910 shares of company stock valued at $9,242,439 in the last three months. Insiders own 0.79% of the company’s stock.

A number of institutional investors have recently made changes to their positions in MON. Pinnacle Financial Partners Inc. purchased a new position in shares of Monsanto during the second quarter valued at approximately $114,000. Bruderman Asset Management LLC purchased a new position in shares of Monsanto during the second quarter valued at approximately $116,000. Tower Research Capital LLC TRC boosted its position in shares of Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after buying an additional 750 shares during the last quarter. JNBA Financial Advisors boosted its position in shares of Monsanto by 3.9% during the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares during the last quarter. Finally, Armbruster Capital Management Inc. boosted its position in shares of Monsanto by 12.2% during the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after buying an additional 125 shares during the last quarter. 74.81% of the stock is owned by hedge funds and other institutional investors.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Analyst Recommendations for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.